Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges.

Introducing new recombinant protein antigens to existing pediatric combination vaccines is important in improving coverage and affordability, especially in low- and middle-income countries (LMICs). This case-study highlights the analytical and formulation challenges encountered with three recombinant non-replicating rotavirus vaccine (NRRV) antigens (t-NRRV formulated with Alhydrogel adjuvant, AH) combined with a mock multidose formulation of a pediatric pentavalent vaccine used in LMICs. This complex formulation contained (1) vaccine antigens (i.

First Complete Genome Sequence of Pepper mild mottle virus from Chili Pepper in the United States.

(PMMoV) was first reported as a latent strain in the United States and then later reported in other countries around the world. Here, we report the first complete genome sequence of a PMMoV isolate (BL14) that was collected from chili pepper during the 2014 growing season in Oklahoma.